Xospata 40 mg, Filmtabletten

7680672110011 CH-67211 Filmtabletten
Xospata 40 mg, Filmtabletten
Xospata 40 mg, Filmtabletten
Xospata 40 mg, Filmtabletten
1 / 3
google

Article details

Package size
84
Selling units
84
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/05/2025
Summary of Product Characteristics
Français
26/05/2025
Summary of Product Characteristics
Italien
26/05/2025
Patient information leaflet
Allemand
21/12/2024
Patient information leaflet
Français
21/12/2024
Patient information leaflet
Italien
21/12/2024

Detailed composition

Substance Quantity Type Category
gilteritinibum
40.0 MG Substance Wirkstoff (Principe actif)
gilteritinibi hemifumaras
- Substance WIZUS
mannitolum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hydroxypropylcellulosum substitutum humile
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK

Reimbursement information

Public price
CHF 14990.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2023

Authorization holder

Astellas Pharma AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
67211
Drug name
Xospata, Filmtabletten
Galenic form
FILM
ATC Code
L01EX13
Authorization status
Z
Dispensing category
A
First authorization
24/09/2020
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Akute myeloide Leukämie (AML)

Package details

Description (FR)
XOSPATA cpr pell 40 mg 84 pce
Description (DE)
XOSPATA Filmtabl 40 mg 84 Stk
Market launch
24/09/2020
Narcotic (BTM)
No
Buy us a coffee Explore the data